Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide.
Flawless balance sheet with proven track record.
Share Price & News
How has Varian Medical Systems's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: VAR's share price has been volatile over the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: VAR underperformed the US Medical Equipment industry which returned 28.4% over the past year.
Return vs Market: VAR underperformed the US Market which returned 24.7% over the past year.
Price Volatility Vs. Market
How volatile is Varian Medical Systems's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StShould You Be Impressed By Varian Medical Systems, Inc.'s (NYSE:VAR) ROE?
1 month ago | Simply Wall StDoes Varian Medical Systems's (NYSE:VAR) Statutory Profit Adequately Reflect Its Underlying Profit?
1 month ago | Simply Wall StVarian Medical Systems (NYSE:VAR) Could Easily Take On More Debt
Is Varian Medical Systems undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: VAR ($148.5) is trading above our estimate of fair value ($135.91)
Significantly Below Fair Value: VAR is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: VAR is good value based on its PE Ratio (46x) compared to the Medical Equipment industry average (46.3x).
PE vs Market: VAR is poor value based on its PE Ratio (46.3x) compared to the US market (18.9x).
Price to Earnings Growth Ratio
PEG Ratio: VAR is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: VAR is overvalued based on its PB Ratio (7.6x) compared to the US Medical Equipment industry average (4.1x).
How is Varian Medical Systems forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VAR's forecast earnings growth (21.2% per year) is above the savings rate (1.7%).
Earnings vs Market: VAR's earnings (21.2% per year) are forecast to grow faster than the US market (14.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: VAR's revenue (8.8% per year) is forecast to grow faster than the US market (7.5% per year).
High Growth Revenue: VAR's revenue (8.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VAR's Return on Equity is forecast to be low in 3 years time (18.3%).
How has Varian Medical Systems performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VAR has high quality earnings.
Growing Profit Margin: VAR's current net profit margins (9.1%) are higher than last year (5.1%).
Past Earnings Growth Analysis
Earnings Trend: VAR's earnings have declined by -11.6% per year over the past 5 years.
Accelerating Growth: VAR's earnings growth over the past year (95.3%) exceeds its 5-year average (-11.6% per year).
Earnings vs Industry: VAR earnings growth over the past year (95.3%) exceeded the Medical Equipment industry 31%.
Return on Equity
High ROE: VAR's Return on Equity (16.4%) is considered low.
Return on Assets
Return on Capital Employed
How is Varian Medical Systems's financial position?
Financial Position Analysis
Short Term Liabilities: VAR's short term assets ($2.4B) exceed its short term liabilities ($1.9B).
Long Term Liabilities: VAR's short term assets ($2.4B) exceed its long term liabilities ($440.1M).
Debt to Equity History and Analysis
Debt Level: VAR's debt to equity ratio (23.1%) is considered satisfactory.
Reducing Debt: VAR's debt to equity ratio has reduced from 27.2% to 23.1% over the past 5 years.
Debt Coverage: VAR's debt is well covered by operating cash flow (90.7%).
Interest Coverage: VAR earns more interest than it pays, so coverage of interest payments is not a concern.
Inventory Level: VAR has a high level of physical assets or inventory.
Debt Coverage by Assets: VAR's debt is covered by short term assets (assets are 5.8x debt).
What is Varian Medical Systems's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate VAR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate VAR's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if VAR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VAR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of VAR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
What is the CEO of Varian Medical Systems's salary, the management and board of directors tenure and is there insider trading?
Average management tenure
Dow Wilson (60yo)
Mr. Dow R. Wilson has been the Chief Executive Officer and President of Varian Medical Systems, Inc. since September 29, 2012. Mr. Wilson has been a Director of Agilent Technologies, Inc. since March 20, 2 ...
CEO Compensation Analysis
Compensation vs Market: Dow's total compensation ($USD9.45M) is about average for companies of similar size in the US market ($USD10.76M).
Compensation vs Earnings: Dow's compensation has been consistent with company performance over the past year.
Management Age and Tenure
Experienced Management: VAR's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Age and Tenure
Experienced Board: VAR's board of directors are considered experienced (4.7 years average tenure).
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
John Kuo (56yo)
- Tenure: 14.5yrs
- Compensation: US$2.26m
Dow Wilson (60yo)
- Tenure: 7.3yrs
- Compensation: US$9.45m
Kolleen Kennedy (60yo)
Chief Growth Officer & President of Proton Solutions
- Compensation: US$3.55m
Mike Bruff (50yo)
Senior VP of Finance & CFO
- Tenure: 0.08yrs
Christopher Toth (40yo)
President of Varian Oncology Systems
- Compensation: US$2.22m
Gary Bischoping (51yo)
President of Interventional Oncology Solutions
- Tenure: 2.7yrs
- Compensation: US$2.58m
VP of Investor Relations & Treasurer
Senior VP & Chief Information Officer
- Tenure: 0.2yrs
Senior Vice President of Global Operations
- Tenure: 0.8yrs
Judy Bruner (60yo)
- Tenure: 3.4yrs
- Compensation: US$281.25k
Andy Eckert (57yo)
- Tenure: 5.9yrs
- Compensation: US$372.00k
Tim Guertin (69yo)
- Tenure: 15yrs
- Compensation: US$246.25k
Phil Febbo (53yo)
- Tenure: 0.4yrs
- Compensation: US$25.00k
Jeff Balser (56yo)
- Tenure: 1.3yrs
- Compensation: US$321.20k
Jean-Luc Butel (63yo)
- Tenure: 2.8yrs
- Compensation: US$272.62k
Dave Illingworth (65yo)
- Tenure: 8.4yrs
- Compensation: US$257.00k
Dow Wilson (60yo)
- Tenure: 7.3yrs
- Compensation: US$9.45m
Regina Dugan (56yo)
- Tenure: 6.1yrs
- Compensation: US$265.75k
Anat Ashkenazi (47yo)
- Tenure: 1.1yrs
- Compensation: US$276.81k
Varian Medical Systems, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Varian Medical Systems, Inc.
- Ticker: VAR
- Exchange: NYSE
- Founded: 1948
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$13.523b
- Shares outstanding: 90.91m
- Website: https://www.varian.com
Number of Employees
- Varian Medical Systems, Inc.
- 3100 Hansen Way
- Palo Alto
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|VAR||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Jan 1968|
|VNM||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Jan 1968|
|0LNU||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Jan 1968|
|VAR *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Jan 1968|
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians’ offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; and partnership agreement with Siemens AG. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/01/17 23:46|
|End of Day Share Price||2020/01/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.